Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Pushing cells towards a higher pluripotency state

24.06.2014

Stem cells have the unique ability to become any type of cell in the body.

Given this, the possibility that they can be cultured and engineered in the laboratory makes them an attractive option for regenerative medicine.

However, some conditions that are commonly used for culturing human stem cells have the potential to introduce contaminants, thus rendering the cells unusable for clinical use. These conditions cannot be avoided, however, as they help maintain the pluripotency of the stem cells.

In a study published in Scientific Reports, a group from the RIKEN Center for Life Science Technologies in Japan has gained new insight into the role of CCL2, a chemokine known to be involved in the immune response, in the enhancement of stem cell pluripotency.

In the study, the researchers replaced basic fibroblast growth factor (bFGF), a critical component of human stem cell culture, with CCL2 and studied its effect. The work showed that CCL2 used as a replacement for bFGF activated the JAK/STAT pathway, which is known to be involved in the immune response and maintenance of mouse pluripotent stem cells.

In addition, the cells cultured with CCL2 demonstrated a higher tendency of colony attachment, high efficiency of cellular differentiation, and hints of X chromosome reactivation in female cells, all markers of pluripotency.

To understand the global effects of CCL2, the researchers compared the transcriptome of stem cells cultured with CCL2 and those with bFGF. They found that stem cells cultured with CCL2 had higher expression of genes related to the hypoxic response, such as HIF2A (EPAS1).

The study opens up avenues for further exploring the relationship between cellular stress, such as hypoxia, and the enhancement of pluripotency in cells. Yuki Hasegawa of CLST, who led the study, says, "Among the differentially expressed genes, we found out that the most significantly differentially expressed ones were those related to hypoxic responses, and hypoxia is known to be important in the progression of tumors and the maintenance of pluripotency.

These results could potentially contribute to greater consistency of human induced pluripotent stem cells (iPSCs), which are important both for regenerative medicine and for research into diseases processes."

As a way to apply CCL2 towards the culturing of human iPSCs with more consistent quality, the researchers developed dishes coated with CCL2 and LIF protein beads. This allowed stem cells to be cultured in a feeder-free condition, preventing the risk that viruses or other contaminants could be transmitted to the stem cells.

While the exact mechanisms of how CCL2 enhances pluripotency has yet to be elucidated, this work highlights the usefulness of CCL2 in stem cell culture.

Jens Wilkinson | Eurek Alert!
Further information:
http://www.riken.jp

Further reports about: CCL2 RIKEN conditions contaminants genes hypoxic pluripotency pluripotent regenerative

More articles from Life Sciences:

nachricht DNA Signature Found in Ice Storm Babies
02.10.2014 | McGill University

nachricht UMN research pinpoints microRNA tied to colon cancer tumor growth
02.10.2014 | University of Minnesota Academic Health Center

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Anzeige

Anzeige

Event News

BrainScaleS Conference: From Neurobiology to New Computer Architectures

25.09.2014 | Event News

17th European Health Forum Gastein: “Electing Health – The Europe We Want”

23.09.2014 | Event News

Future questions regarding data processing

22.09.2014 | Event News

 
Latest News

Stressed Out: Research Sheds New Light on Why Rechargeable Batteries Fail

02.10.2014 | Power and Electrical Engineering

Nanoparticles Accumulate Quickly in Wetland Sediment

02.10.2014 | Ecology, The Environment and Conservation

'Smart' bandage emits phosphorescent glow for healing below

02.10.2014 | Medical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>